Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,626 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Neoadjuvant camrelizumab (an anti-PD-1 antibody) plus chemotherapy or apatinib (a VEGFR-2 inhibitor) for initially unresectable stage II-III non-small-cell lung cancer: a multicentre, two-arm, phase 2 exploratory study.
Xia H, Zhang H, Ruan Z, Zhang H, Sun L, Chen H, Zhou Y, Zhang L, Bian D, Zhu X, Zhang J, Sun F, Yu H, Song N, Liu X, Zhu Y, Zhang H, He W, Chen J, Yang J, Chen G, Xie S, Tang D, Zhang X, Duan L, Zhao D, Li Q, Zhang P, Jiang G. Xia H, et al. Among authors: ruan z. Signal Transduct Target Ther. 2024 Jun 14;9(1):145. doi: 10.1038/s41392-024-01861-w. Signal Transduct Target Ther. 2024. PMID: 38871690 Free PMC article. Clinical Trial.
Evaluating personalized circulating tumor DNA detection for early-stage lung cancer.
Huang H, Kai Z, Wang Y, Zhang X, Wang J, Zhang W, Xue Q, Zhang H, Jin H, Meng P, Zhang S, Yang Y, Yang H, Liang W, Zha G, Luo P, Xu Y, Shi W, Ruan Z. Huang H, et al. Among authors: ruan z. Cancer Med. 2024 May;13(10):e6817. doi: 10.1002/cam4.6817. Epub 2023 Dec 19. Cancer Med. 2024. PMID: 38112031 Free PMC article.
1,626 results